Literature DB >> 1839077

Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies.

P W Parren1, M E Geerts, L C Boeije, L A Aarden.   

Abstract

The isotype of anti-CD3 mAb has a dramatic effect on anti-CD3 induced T-cell activation, as was previously reported for switch variants (IgG2b to IgA) of a high-avidity IgG1 anti-CD3 mAb (CLB-T3/4.1). In order to study and compare the isotype dependency of T-cell activation with anti-CD3 mAb of various mouse and human subclasses, we now prepared recombinant anti-CD3 mAb. The variable region of the anti-CD3 Ig heavy chain was cloned, joined with genes for the heavy chain constant region and expressed in a cell line only secreting autologous mouse chi light chains. Thus we obtained cell lines that produced mouse (m) IgM, mIgG3 and chimaeric mouse/human (h) IgM, hlgG1, hlgG2, hlgG3, hlgG4, hlgE and hlgA2 anti-CD3. The matched set of mouse and mouse/human chimaeric anti-CD3 isotypes switch variants was then used to study activation of T cells in an accessory cell-dependent system. hlgG1, hlgG4, hlgE, mlgG2a and mlgE induced T-cell proliferation in PBMC of all donors tested, whereas PBMC from a subset of donors were unresponsive to stimulation with hlgG2, hlgG3, hlgA2, mlgG1 and mlgG2b anti-CD3 mAb. hlgM, mlgM and mlgA were only able to induce T-cell mitogenesis in combination with PMA. Our panel of anti-CD3 mAb variants may prove a powerful tool to study mouse and human isotype-dependent effector functions and their influence on T-cell activation requirements in detail.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839077     DOI: 10.1016/0923-2494(91)90121-x

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  8 in total

1.  Serum IgG2 concentration is associated with Gm-allotypes of IgG2 but not with the R131H polymorphism of human Fc-gamma receptor type IIa.

Authors:  Heikki Sarvas; Paula Vesterinen; Olli Mäkelä
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

2.  PCR cloning and sequencing of a CD3-specific monoclonal antibody.

Authors:  S Thirion; K Motmans; H Heyligen; J Raus; C Vandevyver
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.

Authors:  R T Meijer; S Surachno; S L Yong; F J Bemelman; S Florquin; I J M Ten Berge; P T A Schellekens
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

4.  Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.

Authors:  Casey T Nishiya; Gayle M Boxx; Kerry Robison; Carol Itatani; Thomas R Kozel; Mason X Zhang
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

5.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

Authors:  P W Parren; P A Warmerdam; L C Boeije; J Arts; N A Westerdaal; A Vlug; P J Capel; L A Aarden; J G van de Winkel
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

6.  Characterization of a surrogate murine antibody to model anti-human CD3 therapies.

Authors:  Fabien Dépis; Eric Hatterer; Romain Ballet; Bruno Daubeuf; Laura Cons; Sophie Glatt; Walter Reith; Marie Kosco-Vilbois; Yann Dean
Journal:  MAbs       Date:  2013-04-18       Impact factor: 5.857

7.  T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv.

Authors:  Kunhong Zhong; Zhiyong Liu; Hongjian Li; Shasha Zhao; Yuelong Wang; Wenhao Guo; Xi Zheng; Hui Yang; Gang Guo; Liangxue Zhou; Jianguo Xu; Aiping Tong
Journal:  Aging (Albany NY)       Date:  2020-06-10       Impact factor: 5.682

8.  Logic-gated antibody pairs that selectively act on cells co-expressing two antigens.

Authors:  Simone C Oostindie; Derek A Rinaldi; Gijs G Zom; Michael J Wester; Desiree Paulet; Kusai Al-Tamimi; Els van der Meijden; Jennifer R Scheick; Tessa Wilpshaar; Bart de Jong; Marloes Hoff-van den Broek; Rachel M Grattan; Janita J Oosterhoff; Julie Vignau; Sandra Verploegen; Peter Boross; Frank J Beurskens; Diane S Lidke; Janine Schuurman; Rob N de Jong
Journal:  Nat Biotechnol       Date:  2022-07-25       Impact factor: 68.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.